Survival is prolonged further (median survival 78 days; P < 0.0001, n = 7) (Figure 1C) in mice with Hmga1 homozygous deficiency, indicating that Hmga1 gene dosage modulates tumor progression in this model. The gene discussed is HMGA1; the disease is neoplasm.